T/SDACM 007-2024 Active Group standards

T/SDACM 007-2024 Stability of traditional Chinese medicine clinical efficacy evaluation indicators for coronary heart disease selection and application guidelines

Publish Date: 2024-11-22 Implement Date: 2024-11-22 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/SDACM 007-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Terminology (principles and coordination and cooperation)

Publish Date: 2024-11-22

Implement Date: 2024-11-22

Scope

Main technical content: According to the data from the "China Cardiovascular Health and Disease Report 2023", the prevalence of cardiovascular diseases in China continues to rise. It is estimated that there are currently about 330 million people suffering from cardiovascular diseases, and cardiovascular diseases remain the leading cause of death. Among various cardiovascular diseases, there are more than 11.39 million patients with coronary heart disease, of which stable coronary heart disease is one of the most common types, and its incidence is also increasing rapidly. Stable coronary heart disease includes three main conditions: chronic stable exertional angina, ischemic cardiomyopathy, and the stable phase after acute coronary syndrome. The treatment goal is mainly to alleviate symptoms and prevent cardiovascular events. Traditional Chinese medicine (TCM) has shown obvious efficacy and unique advantages in treating such diseases, especially in alleviating clinical symptoms and improving patients' quality of life. Although TCM clinical research on stable coronary heart disease has become more standardized in recent years, it still faces some challenges, such as the lack of consistency in the choice of efficacy evaluation indicators among different studies, which affects the accurate evaluation of TCM efficacy and hinders the widespread recognition of research results. To this end, this project team has developed a guideline for the selection and application of efficacy evaluation indicators for stable coronary heart disease in TCM, aiming to provide accurate and systematic evaluation indicators for each type of stable coronary heart disease. This will help standardize the selection and application of indicators in TCM clinical research, ensure the scientificity and rationality of research results, and thus more accurately evaluate the efficacy and safety of TCM in treating stable coronary heart disease. All members of the document preparation working group declar